Cascade Prodrug
Cascade prodrug is developing a novel technology that targets and activates a therapeutic prodrug within solid tumors.
Launch date
Employees
Market cap
-
Enterprise valuation
AUD8—12m (Dealroom.co estimates Apr 2013.)
Eugene Oregon (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
| N/A | $100k | Debt | |
| N/A | $1.3m | Series A | |
N/A | Series B | ||
| N/A | $200k | Series B | |
| Total Funding | AUD2.3m | ||
Related Content
Recent News about Cascade Prodrug
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.